Intralign Health names long-time healthcare businessman new CEO

Intralign Health, an operating room optimization solutions provider, has named a new CEO as it aims to improve its company’s profitability.

Sriram Iyer, who was previously president and CEO of RainTree Oncology, is taking the top position, the company said in a statement. Iyer will be replacing Rick Ferreria, founder of the company and who will be remaining a member of the company’s board.

"Having accomplished our goal of capturing tangible savings for hospitals by optimizing intra-operative processes, Intralign is now focused on creating value-based solutions that enable hospitals to thrive under payment reform,” Ferreria said in a statement. “We are excited to have Sriram lead Intralign's expansion, particularly given his expertise in healthcare analytics and value-based care."

Intralign, based in Scottsdale, Arizona, helps hospitals integrate technology and tools across a range of specialties, but mainly focuses on orthopedics.

Prior to working at RainTree, Iyer was the founder and CEO of Engage Health, a Washington, D.C.-based patient engagement company, and served as an executive at The Advisory Board Company, a research and consulting firm, also in D.C., that services more than 2,500 hospitals.

He holds a bachelor’s in computer science and economics from Dartmouth College and has an MBA from the Wharton School of Business.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.